Revalia Bio Overview
- Year Founded
-
2021
- Status
-
Private
- Employees
-
38
- Latest Deal Type
-
Seed
- Latest Deal Amount
-
$14.5M
- Investors
-
11
Revalia Bio General Information
Description
Developer of a human biology data platform designed to support drug and medical device development using donated organs and tissues. The company's platform generates multimodal datasets from donated human organs and tissues, captures real-time physiological measurements and molecular information across multiple biological scales, integrates human-derived datasets, and applies artificial intelligence foundation models to interpret complex biological data, enabling pharmaceutical and medical device developers to use human-derived evidence to guide research and development decisions.
Contact Information
Website
www.revaliabio.comCorporate Office
- 55 Church Street
- Suite 400
- New Haven, CT 06510
- United States
Corporate Office
- 55 Church Street
- Suite 400
- New Haven, CT 06510
- United States
Revalia Bio Timeline
Revalia Bio Valuation & Funding
| Deal Type | Date | Amount | Raised to Date | Post-Val | Status | Stage |
|---|---|---|---|---|---|---|
| 3. Seed Round | 04-Sep-2025 | $14.5M | Completed | Generating Revenue | ||
| 2. Seed Round | 29-Oct-2024 | Completed | Generating Revenue | |||
| 1. Accelerator/Incubator | Completed | Generating Revenue |
Revalia Bio Cap Table
| Stock | # of Shares Authorized |
Par Value | Dividend Rate (%) | Original Issue Price |
Liquidation | Liquidation Pref. Multiple |
Conversion Price | % Owned |
|---|---|---|---|---|---|---|---|---|
| Seed-1 | ||||||||
| Seed-4 | ||||||||
| Seed-3 | 424,906 | $0.000100 | 8% | $6.66 | $6.66 | 1x | $6.66 | 10.95% |
| Seed-2 | 90,086 | $0.000100 | 8% | $2.22 | $2.22 | 1x | $2.22 | 2.32% |
VC Exit Predictor
See how our proprietary methodology utilizes historical data sets to synthesize the likelihood of an acquisition, IPO, or no exit event. Get a detailed look at the calculations behind our predictions.
Revalia Bio Signals
Revalia Bio Investors (11)
| Investor Name | Investor Type | Holding | Investor Since | Participating Rounds |
|---|---|---|---|---|
| America's Frontier Fund | Venture Capital | Minority | ||
| Pamir Ventures | Venture Capital | Minority | ||
| Angel (individual) | Minority | |||
| Sierra Ventures | Venture Capital | Minority | ||
| BoxOne Ventures | Venture Capital | Minority |
Revalia Bio FAQs
-
When was Revalia Bio founded?
Revalia Bio was founded in 2021.
-
Where is Revalia Bio headquartered?
Revalia Bio is headquartered in New Haven, CT.
-
What is the size of Revalia Bio?
Revalia Bio has 38 total employees.
-
What industry is Revalia Bio in?
Revalia Bio’s primary industry is Discovery Tools (Healthcare).
-
Is Revalia Bio a private or public company?
Revalia Bio is a Private company.
-
What is Revalia Bio’s current revenue?
The current revenue for Revalia Bio is .
-
How much funding has Revalia Bio raised over time?
Revalia Bio has raised $26.8M.
-
Who are Revalia Bio’s investors?
America's Frontier Fund, Pamir Ventures, , Sierra Ventures, and BoxOne Ventures are 5 of 11 investors who have invested in Revalia Bio.
Data Transparency
-
Meet our data hygiene team
Discover how our experts ensure you’re getting the most accurate financial data in the industry.
Read more -
How PitchBook sources data
Our data operations team has logged over 3.5 million hours researching, organizing, and integrating the information you need most.
Discover our process